Page last updated: 2024-08-16

sb 239063 and anisomycin

sb 239063 has been researched along with anisomycin in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cao, W; Chai, W; Li, G; Liu, Z; Wu, Y; Yang, Z1

Other Studies

1 other study(ies) available for sb 239063 and anisomycin

ArticleYear
Activation of p38 mitogen-activated protein kinase abolishes insulin-mediated myocardial protection against ischemia-reperfusion injury.
    American journal of physiology. Endocrinology and metabolism, 2008, Volume: 294, Issue:1

    Topics: Animals; Anisomycin; Cardiotonic Agents; Drug Interactions; Enzyme Activation; Enzyme Inhibitors; Hypoglycemic Agents; Imidazoles; Insulin; Male; MAP Kinase Signaling System; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Myocardial Reperfusion Injury; Myocardium; p38 Mitogen-Activated Protein Kinases; Protein Synthesis Inhibitors; Pyrimidines; Rats; Rats, Sprague-Dawley

2008